LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
LifeVantage (Nasdaq: LFVN), a health and wellness company focused on cellular health products, has announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. The event will take place from September 8-10, 2025, in New York, NY.
President and CEO Steve Fife, along with CFO Carl Aure, will conduct investor meetings and deliver a presentation on Wednesday, September 10, 2025, at 1:00 p.m. Eastern Time. The presentation will be available via live webcast on the company's investor relations website, with a replay accessible for approximately 90 days afterward.
LifeVantage (Nasdaq: LFVN), azienda operante nel settore della salute e del benessere con focus sui prodotti per la salute cellulare, ha confermato la propria partecipazione al 27掳 Annual Global Investment Conference di H.C. Wainwright. L'evento si terr脿 dall'8 al 10 settembre 2025 a New York, NY.
Il Presidente e CEO Steve Fife e il CFO Carl Aure incontreranno investitori e terranno una presentazione mercoled矛 10 settembre 2025 alle 13:00 ora Eastern. La presentazione sar脿 trasmessa in diretta via webcast sul sito investor relations della societ脿 e la registrazione sar脿 disponibile in replay per circa 90 giorni.
LifeVantage (Nasdaq: LFVN), empresa de salud y bienestar centrada en productos para la salud celular, ha anunciado su participaci贸n en la 27陋 Conferencia Anual Global de Inversi贸n de H.C. Wainwright. El evento se celebrar谩 del 8 al 10 de septiembre de 2025 en Nueva York, NY.
El presidente y CEO Steve Fife, junto con el CFO Carl Aure, mantendr谩n reuniones con inversores y ofrecer谩n una presentaci贸n el mi茅rcoles 10 de septiembre de 2025 a la 1:00 p.m. hora del Este. La presentaci贸n se transmitir谩 en vivo por webcast en la web de relaciones con inversores de la compa帽铆a y la repetici贸n estar谩 disponible durante aproximadamente 90 d铆as.
LifeVantage (Nasdaq: LFVN)電� 靹疙彫 瓯搓皶 鞝滍拡鞐� 欷戩爯鞚� 霊� 瓯搓皶路鞗半媹鞀� 旮办梾鞙茧, 雼り皜鞓る姅 H.C. Wainwright 鞝�27須� 鞐半 旮�搿滊矊 韴瀽 旖橅嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 頄夓偓電� 2025雲� 9鞗� 8鞚茧秬韯� 10鞚缄箤歆� 雺挫殨, NY鞐愳劀 鞐措雼堧嫟.
靷灔 瓴� CEO 鞀ろ嫲敫� 韺岇澊頂�(Steve Fife)鞕� 鞛毂呾瀯鞛� 旃� 鞎勳毎霠�(Carl Aure)臧� 韴瀽鞛� 氙疙寘鞚� 歆勴枆頃橁碃, 2025雲� 9鞗� 10鞚� 靾橃殧鞚� 霃欕秬鞁滉皠 鞓ろ泟 1鞁�鞐� 頂勲爤鞝犿厡鞚挫厴鞚� 鞁れ嫓頃╇媹雼�. 氚滍憸電� 須岇偓鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 霛检澊敫� 鞗箘旌愳姢韸鸽 欷戧硠霅橂┌, 鞎� 90鞚缄皠 鞛嫓觳澊 臧�電ロ暕雼堧嫟.
LifeVantage (Nasdaq: LFVN), soci茅t茅 sp茅cialis茅e dans la sant茅 et le bien鈥懨猼re ax茅e sur des produits pour la sant茅 cellulaire, a annonc茅 sa participation 脿 la 27e conf茅rence annuelle mondiale d'investissement H.C. Wainwright. L'茅v茅nement se tiendra du 8 au 10 septembre 2025 脿 New York (NY).
Le pr茅sident鈥慸irecteur g茅n茅ral Steve Fife, accompagn茅 du directeur financier Carl Aure, tiendra des r茅unions avec des investisseurs et pr茅sentera le mercredi 10 septembre 2025 脿 13h00, heure de l'Est. La pr茅sentation sera diffus茅e en direct via webcast sur le site des relations investisseurs de la soci茅t茅 et le replay restera accessible pendant environ 90 jours.
LifeVantage (Nasdaq: LFVN), ein Unternehmen im Bereich Gesundheit und Wellness mit Schwerpunkt auf zellul盲ren Gesundheitsprodukten, hat seine Teilnahme an der 27. H.C. Wainwright Annual Global Investment Conference angek眉ndigt. Die Veranstaltung findet vom 8. bis 10. September 2025 in New York, NY statt.
Pr盲sident und CEO Steve Fife sowie CFO Carl Aure werden Investoren treffen und am Mittwoch, dem 10. September 2025 um 13:00 Uhr Eastern Time, eine Pr盲sentation halten. Die Pr盲sentation wird live per Webcast auf der Investor-Relations-Website des Unternehmens 眉bertragen; ein Replay ist f眉r etwa 90 Tage verf眉gbar.
- None.
- None.
SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 27th Annual Global Investment Conference, to be held September 8-10, 2025 in New York, NY.
Mr. Fife and Mr. Aure will meet with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, September 10, 2025. A live webcast of their presentation will be accessible on the News & Events section of the Company鈥檚 Investor Relations website at聽 or directly . A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company鈥檚 website.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics鈥攖he study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim庐 family of products, TrueScience庐 Liquid Collagen, the newest MindBody GLP-1 System鈩�, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System庐, as well as AXIO庐 nootropic energy drink mixes, the full TrueScience庐 line of skin and hair care products, and Petandim庐, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit .
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
[email protected]
FAQ
When is LifeVantage (LFVN) presenting at the H.C. Wainwright Conference 2025?
Who will represent LifeVantage (LFVN) at the H.C. Wainwright Conference?
How can investors access LifeVantage's (LFVN) H.C. Wainwright Conference presentation?
What is the duration of the H.C. Wainwright Conference 2025?
